Cargando…

Tenecteplase real-world data: A three phase sequential comparison

INTRODUCTION: The New Zealand (NZ) Central Region Stroke Network, serving 1.17 million catchment population, changed to tenecteplase for stroke thrombolysis in 2020 but was forced to revert to Alteplase in 2021 due to a sudden cessation of drug supply. We used this unique opportunity to assess for p...

Descripción completa

Detalles Bibliográficos
Autores principales:	Ranta, Anna, Tyson, Alicia, Lallu, Bhavesh, Wu, Teddy Y, Punter, Martin, Manoczki, Csilla, Chalissery, John, Pillai, Akesh, Mahawish, Karim, Conde, Roldan, Falconer, Marianne, Wills, Karyn, Gunawardana, Chaminda, Busch, Suzanne, Gommans, John
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	SAGE Publications 2023
Materias:	Original Research Articles
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10683726/ https://www.ncbi.nlm.nih.gov/pubmed/37489615 http://dx.doi.org/10.1177/23969873231187436

Ejemplares similares

Trail Toward Tenecteplase
por: Srivastava, Trilochan, et al.
Publicado: (2022)

Expanding Footprints of Biosimilar Tenecteplase
por: Subhash, et al.
Publicado: (2023)

Intracoronary tenecteplase in STEMI with massive thrombus
por: Jayagopal, P.B., et al.
Publicado: (2018)

Tenecteplase: Haemorrhagic pericarditis: case report
Publicado: (2020)

Tenecteplase Thrombolysis in Posterior Circulation Stroke
por: Alemseged, Fana, et al.
Publicado: (2021)

Tenecteplase in Ischemic Stroke: Challenge and Opportunity
por: Li, Guangshuo, et al.
Publicado: (2022)

Replacing Alteplase with Tenecteplase: Is the Time Ripe?
por: Singh, Nishita, et al.
Publicado: (2023)

The Norwegian tenecteplase stroke trial (NOR-TEST): randomised controlled trial of tenecteplase vs. alteplase in acute ischaemic stroke
por: Logallo, Nicola, et al.
Publicado: (2014)

Intrapleural Tenecteplase for Complicated Parapneumonic Pleural Effusion
por: Kadhem, Husain, et al.
Publicado: (2021)

Tenecteplase or Alteplase: What Is the Thrombolytic Agent of the Future?
por: Mahmood, Ammad, et al.
Publicado: (2022)

Case report: marantic endocarditis in renal cell carcinoma: nephrectomy a treatment
por: Harris, Andrew Z, et al.
Publicado: (2021)

Review of tenecteplase (TNKase) in the treatment of acute myocardial infarction
por: Melandri, Giovanni, et al.
Publicado: (2009)

Early Experience With Tenecteplase at a Comprehensive Stroke Center
por: Panezai, Spozhmy, et al.
Publicado: (2021)

Alteplase or tenecteplase for thrombolysis in ischemic stroke: An illustrated review
por: Zhu, Annie, et al.
Publicado: (2022)

Using Tenecteplase for Acute Ischemic Stroke: What Is the Hold Up?
por: Zitek, Tony, et al.
Publicado: (2020)

Enoxaparin sodium/heparin/tenecteplase: Haematoma: 6 case reports
Publicado: (2022)

Cost-effectiveness of tenecteplase versus alteplase for acute ischemic stroke
por: Nguyen, Chi Phuong, et al.
Publicado: (2023)

Intravenous thrombolysis for acute ischemic stroke: From alteplase to tenecteplase
por: Yang, Nan, et al.
Publicado: (2023)

GUILLAIN-BARRÉ SYNDROME FOLLOWING COVID-19 PNEUMONIA: ARE THEY RELATED?
por: THOMAS, AKESH, et al.
Publicado: (2021)

Lingual Haematoma due to Tenecteplase in a Patient with Acute Myocardial Infarction
por: Bal, Muhlis, et al.
Publicado: (2013)

Tenecteplase compared with streptokinase and heparin in the treatment of pulmonary embolism: an observational study
por: Agrawal, Ashish, et al.
Publicado: (2017)

Tenecteplase vs. alteplase for acute ischemic stroke: a systematic review
por: Potla, Neha, et al.
Publicado: (2022)

Re: Tenecteplase for thrombolysis in stroke patients: Systematic review with meta-analysis
por: Bahadori, Maryam, et al.
Publicado: (2022)

Tenecteplase in Pulmonary Embolism Patients: A Meta-Analysis and Systematic Review
por: Zhang, Zhu, et al.
Publicado: (2022)

Is Tenecteplase a Viable Alternative to Alteplase in the Treatment of Acute Ischemic Stroke?
por: Vaishnav, Anand Girish
Publicado: (2022)

Switching to Tenecteplase from Alteplase for Ischemic Stroke: Is it the Time for Universal Adoption?
por: Kharel, Sanjeev, et al.
Publicado: (2022)

Thrombolysis for acute ischemic stroke by tenecteplase in the emergency department of a Moroccan hospital
por: Belkouch, Ahmed, et al.
Publicado: (2015)

Acute Ischemic Stroke Thrombolysis with Tenecteplase: An Institutional Experience from South India
por: Owais, Mohammed, et al.
Publicado: (2018)

Tenecteplase versus streptokinase thrombolytic therapy in patients with mitral prosthetic valve thrombosis
por: Kathirvel, D., et al.
Publicado: (2018)

Recanalization before Thrombectomy in Tenecteplase vs. Alteplase-Treated Drip-and-Ship Patients
por: Seners, Pierre, et al.
Publicado: (2019)

In vitro examination of the thrombolytic efficacy of tenecteplase and therapeutic ultrasound compared to rt-PA
por: Frühwald, Tobias, et al.
Publicado: (2019)

Successful thrombolysis of left subclavian arterial thrombosis with intravenous bolus dose of tenecteplase
por: Akkala, Raghavender, et al.
Publicado: (2017)

Is tenecteplase ready to replace alteplase to treat acute ischaemic stroke? The knowns and unknowns
por: Dong, Yi, et al.
Publicado: (2021)

Spinal Epidural Hematoma Secondary to Tenecteplase for ST-Elevation Myocardial Infarction in the Setting of Trauma and Cervical Endplate Fracture
por: Parr, Christopher J., et al.
Publicado: (2019)

An Unusual Presentation of a Massive Pulmonary Embolism with Misleading Investigation Results Treated with Tenecteplase
por: Migneault, David, et al.
Publicado: (2015)

Erratum: Acute Ischemic Stroke Thrombolysis with Tenecteplase: An Institutional Experience from South India
Publicado: (2018)

Tenecteplase in wake-up ischemic stroke trial: Protocol for a randomized-controlled trial
por: Roaldsen, Melinda B, et al.
Publicado: (2021)

Clinical outcomes of patients with mitral prosthetic valve obstructive thrombosis treated with streptokinase or tenecteplase
por: Kiran, G. Ravi, et al.
Publicado: (2021)

Biosimilar Tenecteplase Versus Alteplase in Acute Ischemic Stroke: A Real World Study
por: Mohan, Ayush, et al.
Publicado: (2023)

Comparison of clot lysis activity and biochemical properties of originator tenecteplase (Metalyse(®)) with those of an alleged biosimilar
por: Kliche, Werner, et al.
Publicado: (2014)

Cannot write session to /tmp/vufind_sessions/sess_4tkv2rugfh0k0dn9k3679onqp4